Five prognostic genes DDX47, RPL17, AS3MT, KLRK1, and S100A8 were found to be unfavorable for the survival of PRAD bone metastases; their expression was considerably higher in the high-risk group than in the low-risk group. This evidence concerns the gene AS3MT and prostate adenocarcinoma.